REG - Itaconix PLC - Full Year Trading Update

ItaconixAnnouncement

Today 07:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260113:nRSM5928Oa&default-theme=true

RNS Number : 5928O  Itaconix PLC  13 January 2026

For release: 07.00, 13 January
2026
 

Itaconix plc

("Itaconix" or the "Company")

Full Year Trading Update

Record revenues exceeding $10 million for the first time, driven by third
consecutive record half year and strong customer momentum

Itaconix plc (AIM: ITX) (OTCQB: ITXXF), a leading innovator in
high-performance plant-based specialty polymers, is pleased to provide a
trading update for the year ended 31 December 2025.

Unaudited revenues for FY 2025 increased 59% year-on-year to $10.3 million (FY
2024: $6.5 million), exceeding $10 million for the first time. This
performance was underpinned by a third consecutive record half year, with
revenues of $5.5 million in H2 2025, up from $4.8 million in H2 2024.

Revenue growth was generated across both existing and new customers, spanning
major applications and geographies. Demand for the Company's patented
plant-based polymers continued to strengthen as global consumer product
manufacturers increasingly adopt sustainable, high-performance ingredients to
enhance formulation performance and deliver added value in detergent, hygiene
and beauty products. This growth in revenue and a step change in the Company's
commercial traction have enabled Itaconix to invest further in demand
generation and support for 2026.

The Board remains optimistic about the Company's prospects for 2026 and
believes that Itaconix is well positioned to deliver continued revenue growth,
supported by a growing customer pipeline, expanding product adoption and a
scalable, capital-efficient operating model.

Further details on 2025 trading performance and the outlook for 2026 will be
provided with the Company's FY 2025 results, expected in late March 2026.

John R. Shaw, CEO of Itaconix, commented:

"2025 was a milestone year for Itaconix. Delivering record revenues of over
$10 million for the first time, alongside our third consecutive record half
year, demonstrates the accelerating commercial momentum behind our technology
and customer proposition.

"We are seeing growing validation from both new and existing customers as our
plant-based specialty polymers become embedded in next-generation consumer
products where performance, sustainability and value are all critical.

"Entering 2026, Itaconix is operating from a position of strength: we are well
funded, capital efficient and supported by a deep and expanding revenue
pipeline. With increasing scale, disciplined execution and strong customer
engagement, we believe the Company is firmly on track towards building a
large, profitable and enduring specialty ingredients business, delivering
long-term value for shareholders."

- ends -

Enquiries:

Itaconix plc
 
 
             +1 603 775 4400

John R. Shaw / Laura Denner

Rosewood
 
 
    +44 (0) 207 653 8704

Financial PR

John West / Llewellyn Angus / Lily Pearce

Canaccord Genuity
 
 
 +44 (0) 7523 8000

Nominated Adviser and Broker

Adam James / Harry Pardoe

 

About Itaconix

Itaconix uses its proprietary plant-based polymer technology platform to
produce and sell specialty ingredients that improve the safety, performance,
and sustainability of consumer products. The Company's current ingredients are
enabling and leading new generations of cost-effective, decarbonized consumer
products in home and personal care.

www.itaconix.com (http://www.itaconix.com)

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  TSTBIGDBXBBDGLD



            Copyright 2019 Regulatory News Service, all rights reserved